This report on the pharmaceutical excipient market covers an overview of excipients, classification of excipients, and their significance in the pharmaceutical industry. A detailed analysis illustrating market dynamics, market structure analysis incorporating Porter’s Five Force Framework analysis and supply chain and distribution is discussed in detail. Excluded from the scope of this report is the use of excipients in cosmetics, food and beverage, and chemical industries. Emerging pharmaceutical excipients such as co-processed and multifunctional excipients and their impact on the future of pharmaceutical excipients market is also analyzed.
Based on the type of material, the pharmaceutical excipient market is segmented into organic excipients, inorganic excipients and USP Water. Based on route of administration, the pharmaceutical excipient market is segmented by-oral, injectable/parenteral, topical and advanced delivery systems. By dosage forms, the pharmaceutical excipients market is segmented as solid dosage forms, liquid dosage forms, semi-solid dosage forms, and others (e.g., aerosol and powder). By end user, the market is segmented into pharmaceutical and biopharmaceutical companies, contract formulators and others (e.g., academics and pharmacies). This report includes market size estimates for 2016 as the base year, 2017, and forecast estimates for 2022.
Geographically, this report analyzes the market by the following regions: North America, Europe, Asia-Pacific, Latin America and the Middle East. Key countries with a high concentration of pharma manufacturing companies and contract manufacturing organizations, including the U.S., Europe (Germany, U.K., Italy, France and Spain), China, India and Brazil are discussed. A detailed competitive analysis of key leading pharmaceutical excipient suppliers is provided, detailing business operations and segment focus.
– 58 tables
– An overview of the global market for excipients in pharmaceuticals
– Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
– Detailed analyses of organic and inorganic excipients
– Discussion of various excipient interactions, including drug-excipient interaction, excipient-excipient interaction, and package-excipient interaction
– Insight into the most critical issues surrounding excipients, including technological, regulatory, economic, and political
– Company profiles of major players in the market, including Ashland Global Holdings, Inc., Cargill, Inc, Meggle Pharma Gmbh, The Lubrizol Corporation and Omya Ag
Reasons for Doing This Study
This dynamic market is undergoing changes in the context of new developments, such as product launches, mergers and acquisitions and partnership activities. The pharmaceutical market landscape has been undergoing myriad changes relative to outsourcing activities and patent expirations. The perceptions of different stakeholders in the pharmaceutical industry and the overall attractiveness of the market is the focus of the analysis in this report.ASHLAND GLOBAL HOLDINGS INC.
Avantor Performance Materials Inc
CTD HOLDINGS INC.
Dowdupont (the Dow Chemical Company)
Meggle Pharma Gmbh
MERCK & CO., INC.
THE LUBRIZOL CORPORATION
Table of Content: Key Points
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Chapter 2 Summary and Highlights
Highlights in the Global Market for Pharmaceutical Excipients:
Chapter 3 Market Definition, Sources and Interactions
Excipient in Pharmaceuticals-Definition
Sources of Excipients
Co-processed Excipients (CE)
Multi-functional Excipients (ME)
Get in touch:
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349